View Older Stories View More Recent Stories

Dec 29, 2025 12:03PM Truist Securities Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Dec 29, 2025 08:25AM Ultragenyx Pharma (RARE) halted, news pending

Nov 21, 2025 07:13AM Cantor Fitzgerald Reiterates Overweight Rating on Ultragenyx Pharma (RARE)

Nov 5, 2025 09:34AM Citi Opens 90-Day Upside Catalyst Watch on Ultragenyx Pharma (RARE)

Nov 5, 2025 04:51AM Ultragenyx Pharma (RARE) PT Lowered to $72 at RBC Capital

Nov 4, 2025 04:19PM Ultragenyx Pharma (RARE) Misses Q3 EPS by 58c, provides guidance

Oct 17, 2025 05:56AM Ultragenyx Pharma (RARE) January 50 calls active

Sep 22, 2025 07:15AM Cantor Fitzgerald Reiterates Overweight Rating on Ultragenyx Pharma (RARE)

Sep 9, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Aug 18, 2025 08:06AM Ultragenyx begins rolling FDA submission for GSDIa gene therapy

Jul 28, 2025 06:58AM H.C. Wainwright Assumes Ultragenyx Pharma (RARE) at Buy

Jul 14, 2025 08:01AM Health Canada approves Evkeeza for infants as young as 6 months with HoFH

Jul 14, 2025 05:08AM Ultragenyx Pharma (RARE) December options active

Jul 11, 2025 05:05PM Ultragenyx stock falls after FDA issues complete response letter for gene therapy

Jul 11, 2025 04:30PM Ultragenyx receives FDA rejection for gene therapy to treat rare disease

Jul 10, 2025 10:52AM TD Cowen: 'Ultragenyx Pharma (RARE) a Buying Oppy Ahead Of Dec '25 Readout'

Jul 10, 2025 07:49AM BTIG Reiterates Buy Rating on Mereo BipPharma Group (MREO)

Jul 10, 2025 07:43AM Morgan Stanley Reiterates Overweight Rating on Ultragenyx Pharma (RARE)

Jul 10, 2025 06:44AM Canaccord Genuity Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Jul 10, 2025 06:42AM Ultragenyx Pharma (RARE) PT Lowered to $65 at Wells Fargo

Jul 10, 2025 06:20AM BofA Securities on Ultragenyx Pharma (RARE): 'top 2025 pick'

Jul 10, 2025 06:01AM Goldman Sachs Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Jul 10, 2025 05:50AM Citi Opens 90d Upside Cat Call on Ultragenyx Pharma (RARE)

Jul 9, 2025 04:51PM After-hours movers: WK Kellogg, Costco, Ultragenyx Pharma

Jul 9, 2025 04:05PM Ultragenyx and Mereo advance UX143 osteogenesis imperfecta study to final analysis

Jun 27, 2025 08:00AM Ultragenyx Pharma (RARE) Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome

Jun 23, 2025 10:33AM TD Cowen's Best Smidcap Ideas 2025

May 28, 2025 05:06AM William Blair Starts Ultragenyx Pharma (RARE) at Outperform

May 6, 2025 04:48PM Ultragenyx Pharma (RARE) Misses Q1 EPS by 1c, provides guidance

Apr 22, 2025 03:22PM Ultragenyx Pharma (RARE) spreader of 1K contracts of July 30 puts, July 40 calls and July 50 calls

Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald

Mar 19, 2025 06:43AM Mereo and Ultragenyx remain top picks at Cantor Fitzgerald

Mar 17, 2025 08:13AM Ultragenyx Pharma (RARE) PT Lowered to $115 at Piper Sandler 'Ahead of Near-Term Value Inflection'

Feb 26, 2025 09:10AM Cantor Fitzgerald Reiterates Overweight Rating on Ultragenyx Pharma (RARE)

Feb 19, 2025 07:13AM H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Feb 18, 2025 08:07AM Ultragenyx Pharma (RARE) Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A

Feb 18, 2025 06:52AM Ultragenyx Pharma (RARE) PT Raised to $136 at Canaccord Genuity

Feb 14, 2025 07:16AM Cantor Fitzgerald Reiterates Overweight Rating on Ultragenyx Pharma (RARE)

Feb 14, 2025 06:57AM Goldman Sachs Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Feb 13, 2025 08:55PM Truist Securities Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Feb 13, 2025 04:50PM Ultragenyx Pharma (RARE) Misses Q4 EPS by 5c; offers guidance

Feb 5, 2025 08:00AM Ultragenyx Pharma (RARE) Announces New Data Demonstrating that Treatment with UX111 AAV Gene Therapy Significantly Improved Clinical Function Across Multiple Developmental Domains in Children with San

Jan 13, 2025 05:22AM Goldman Sachs on Ultragenyx Pharma (RARE): 'we remain constructive'

Jan 8, 2025 08:14AM RBC Capital on Ultragenyx Pharma (RARE): 'We Believe RARE Has A Drug For Osteogenesis Imperfecta'

Dec 24, 2024 06:51AM H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Dec 21, 2024 10:00AM RBC report: Biotech faces both uncertainty and growth opportunities in 2025

Dec 20, 2024 09:30AM Buy this biotech stock for 2025: Jefferies

Dec 19, 2024 08:02AM Ultragenyx Pharma (RARE) Submits Biologics License Application to the U.S. FDA for UX111 AAV Gene Therapy for the Treatment of Sanfilippo Syndrome Type A

Dec 17, 2024 06:17AM BofA Updates Endeavor List

Dec 5, 2024 03:13PM Ultragenyx Pharma (RARE) 1K contracts of July 60 calls trade

View More Recent Stories View Older Stories